drugset / Trial / NCT00039442
Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer
NaSingle-groupOpen-labelTreatment
Summary
Phase II trial to study the effectiveness of capecitabine in treating patients who have persistent or recurrent cervical cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.
Timeline
- Start
- 2002-04-29
- Primary completion
- 2005-12-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | — | Oral |